Montserrat García-Closas
#148,765
Most Influential Person Now
Spanish academic and researcher
Montserrat García-Closas's AcademicInfluence.com Rankings
Montserrat García-Closasmedical Degrees
Medical
#2926
World Rank
#3371
Historical Rank
Epidemiology
#569
World Rank
#593
Historical Rank
Montserrat García-Closasmathematics Degrees
Mathematics
#7217
World Rank
#9850
Historical Rank
Statistics
#787
World Rank
#875
Historical Rank
Measure Theory
#1958
World Rank
#2380
Historical Rank
Download Badge
Medical Mathematics
Montserrat García-Closas's Degrees
- Masters Statistics University of Barcelona
- Bachelors Mathematics University of Barcelona
Similar Degrees You Can Earn
Why Is Montserrat García-Closas Influential?
(Suggest an Edit or Addition)According to Wikipedia, Montserrat García-Closas, M.D., M.P.H., Dr.P.H., is a Spanish researcher and academic who is best known for her works on identifying cancer biomarkers and genetic susceptibility to cancer. Dr. García-Closas serves as the deputy director of the Division of Cancer Epidemiology & Genetics of the National Cancer Institute, as well as the Acting Chief of the Integrative Tumor Epidemiology Branch of the DCEG.
Montserrat García-Closas's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genome-wide association study identifies novel breast cancer susceptibility loci (2007) (2351)
- Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. (2004) (1172)
- Large-scale genotyping identifies 41 new loci associated with breast cancer risk (2013) (1063)
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies (2010) (1025)
- Association analysis identifies 65 new breast cancer risk loci (2017) (922)
- Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies (2004) (629)
- Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. (2004) (616)
- Type I and II endometrial cancers: have they different risk factors? (2013) (597)
- A common coding variant in CASP8 is associated with breast cancer risk (2007) (591)
- A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) (2009) (578)
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (559)
- MicroRNA Related Polymorphisms and Breast Cancer Risk (2014) (557)
- Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. (2012) (544)
- Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. (2011) (536)
- Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (2013) (534)
- Detectable clonal mosaicism and its relationship to aging and cancer (2012) (512)
- Parent-of-origin specific allelic associations among 106 genomic loci for age at menarche (2014) (511)
- Developing and evaluating polygenic risk prediction models for stratified disease prevention (2016) (509)
- Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer (2015) (502)
- Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 (2009) (502)
- Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study (2007) (474)
- Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants (2015) (471)
- NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses (2005) (468)
- Performance of common genetic variants in breast-cancer risk models. (2010) (430)
- A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci (2010) (423)
- Genome-wide association studies identify four ER negative–specific breast cancer risk loci (2013) (411)
- Genetic susceptibility to breast cancer (2010) (394)
- Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics (2008) (390)
- Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer (2013) (377)
- RAD51B in Familial Breast Cancer (2016) (366)
- GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer (2013) (350)
- A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 (2010) (341)
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. (2013) (339)
- BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors (2019) (325)
- Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. (2020) (322)
- Large-scale genomic analyses link reproductive ageing to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair (2015) (308)
- A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 (2009) (305)
- Genome-wide association analysis identifies three new breast cancer susceptibility loci (2012) (291)
- Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. (2002) (262)
- Common variants at 19p13 are associated with susceptibility to ovarian cancer (2010) (262)
- Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. (2016) (250)
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
- Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. (2008) (229)
- Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. (2013) (225)
- Cancer therapy shapes the fitness landscape of clonal hematopoiesis (2020) (218)
- Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent (2016) (205)
- Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. (1999) (200)
- Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. (2011) (192)
- Identification of Novel Genetic Markers of Breast Cancer Survival (2015) (185)
- A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. (2012) (182)
- Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. (2013) (180)
- Smoking and Bladder Cancer in Spain: Effects of Tobacco Type, Timing, Environmental Tobacco Smoke, and Gender (2006) (174)
- PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS (2016) (174)
- Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer (2013) (167)
- PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2 (2012) (165)
- CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. (2012) (164)
- Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses (2006) (162)
- Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors (2013) (159)
- Established breast cancer risk factors by clinically important tumour characteristics (2006) (158)
- Genetic Variation in the Nucleotide Excision Repair Pathway and Bladder Cancer Risk (2006) (155)
- Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. (2012) (154)
- Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. (2016) (154)
- Genetic Polymorphisms in Base-Excision Repair Pathway Genes and Risk of Breast Cancer (2006) (150)
- A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (149)
- Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. (2016) (146)
- Genome-Wide Association Studies, Field Synopses, and the Development of the Knowledge Base on Genetic Variation and Human Diseases (2009) (144)
- Application of Biomarkers in Cancer Epidemiology (1997) (144)
- Genome-wide association study identifies a common variant associated with risk of endometrial cancer (2011) (142)
- Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status (2008) (139)
- Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. (2007) (136)
- Genome-wide association study identifies multiple loci associated with bladder cancer risk. (2014) (136)
- Loss of antigenicity in stored sections of breast cancer tissue microarrays. (2004) (134)
- Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. (2015) (133)
- Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors (2016) (133)
- Large-Scale Evaluation of Candidate Genes Identifies Associations between VEGF Polymorphisms and Bladder Cancer Risk (2007) (130)
- Intrauterine environments and breast cancer risk: meta-analysis and systematic review (2008) (125)
- Genetic polymorphisms in the one‐carbon metabolism pathway and breast cancer risk: A population‐based case–control study and meta‐analyses (2007) (123)
- Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome. (2010) (123)
- Identification of nine new susceptibility loci for endometrial cancer (2018) (122)
- Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 (2016) (122)
- Genetic variation in the base excision repair pathway and bladder cancer risk (2007) (121)
- NAT 2 slow acetylation , GSTM 1 null genotype , and risk of bladder cancer : results from the Spanish Bladder Cancer Study and meta-analyses (2005) (120)
- Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk (2013) (120)
- Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. (2010) (119)
- Personalized early detection and prevention of breast cancer: ENVISION consensus statement (2020) (117)
- Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. (2009) (116)
- DNA Banking for Epidemiologic Studies: A Review of Current Practices (2002) (116)
- 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. (2012) (115)
- Mosaic loss of chromosome Y is associated with common variation near TCL1A (2016) (114)
- Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre‐menopausal women (2002) (113)
- Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. (2009) (113)
- Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2014) (112)
- Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31 (2013) (110)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
- Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. (2013) (109)
- Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. (2015) (107)
- Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. (2008) (105)
- Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. (2013) (104)
- Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study (2010) (100)
- Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer (2008) (100)
- Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer. (2014) (98)
- A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. (2011) (97)
- Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis (2015) (96)
- Association of ESR1 gene tagging SNPs with breast cancer risk. (2009) (95)
- The role of genetic breast cancer susceptibility variants as prognostic factors. (2012) (95)
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (95)
- Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. (2007) (94)
- Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. (2007) (93)
- Risk of Bladder Cancer Associated with Family History of Cancer: Do Low-Penetrance Polymorphisms Account for the Increase in Risk? (2007) (93)
- Consortium analysis of 7 candidate SNPs for ovarian cancer (2008) (91)
- Differential misclassification and the assessment of gene-environment interactions in case-control studies. (1998) (91)
- Characterization of large structural genetic mosaicism in human autosomes. (2015) (91)
- Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. (2011) (90)
- Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. (2011) (90)
- Cigarette smoking and cancer risk: modeling total exposure and intensity. (2007) (89)
- ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study (2010) (88)
- Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. (2014) (88)
- Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. (2016) (87)
- Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium. (2018) (86)
- Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. (2015) (86)
- No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing (2016) (83)
- Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data (2016) (83)
- LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. (2011) (82)
- Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk (2012) (81)
- Genetic variation in five genes important in telomere biology and risk for breast cancer (2007) (80)
- Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. (2018) (80)
- BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016) (76)
- Genetic and Non-genetic Predictors of LINE-1 Methylation in Leukocyte DNA (2013) (75)
- Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. (2009) (75)
- Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
- Polymorphisms in one‐carbon metabolism and trans‐sulfuration pathway genes and susceptibility to bladder cancer (2007) (74)
- Comparison of yield and genotyping performance of multiple displacement amplification and OmniPlex™ whole genome amplified DNA generated from multiple DNA sources (2005) (73)
- Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF–LTA) and breast cancer risk (2007) (72)
- Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome (2016) (72)
- Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium (2009) (69)
- Genetic modifiers of CHEK2*1100delC associated breast cancer risk (2016) (68)
- Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. (2012) (68)
- The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer (2006) (68)
- Genetic susceptibility to distinct bladder cancer subphenotypes. (2010) (67)
- Shared heritability and functional enrichment across six solid cancers (2018) (67)
- Expression of TGF-β signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics (2010) (67)
- BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. (2017) (67)
- Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer. (2004) (66)
- Two Estrogen-Related Variants in CYP19A1 and Endometrial Cancer Risk: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (2009) (66)
- Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype. (2018) (64)
- A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States) (1997) (64)
- Leukocyte telomere length in a population-based case–control study of ovarian cancer: a pilot study (2009) (64)
- Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer Susceptibility “Hot-Spot” (2010) (64)
- Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer (2015) (63)
- Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation (2016) (63)
- Adulthood Lifetime Physical Activity and Breast Cancer (2008) (63)
- Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium (2014) (62)
- Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer (2007) (62)
- Genome-wide association study identifies a novel variant in RAD51B associated with male breast cancer risk (2012) (61)
- Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (60)
- Comparative validation of breast cancer risk prediction models and projections for future risk stratification (2018) (60)
- Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study. (2007) (60)
- The Obesity-Associated Polymorphisms FTO rs9939609 and MC4R rs17782313 and Endometrial Cancer Risk in Non-Hispanic White Women (2011) (60)
- Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions (2007) (60)
- A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background (2010) (60)
- Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status (2012) (59)
- Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis (2008) (59)
- Epidemiologic determinants of vaginal pH. (1999) (58)
- Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus (2016) (58)
- Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups (2016) (57)
- Detection of Somatic Mutations by High-Resolution DNA Melting (HRM) Analysis in Multiple Cancers (2011) (56)
- DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations (2009) (56)
- Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. (2010) (56)
- Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study (2014) (56)
- Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain. (2006) (55)
- Use of Analgesics and Nonsteroidal Anti-inflammatory Drugs, Genetic Predisposition, and Bladder Cancer Risk in Spain (2006) (55)
- Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers (2019) (55)
- Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: A population‐based analysis (2007) (55)
- Discovery and validation of methylation markers for endometrial cancer (2014) (55)
- Lessons Learned From Past Gene-Environment Interaction Successes (2017) (54)
- Genetic variation in TP53 and risk of breast cancer in a population-based case control study. (2007) (54)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (53)
- Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. (2009) (53)
- Genetic Variations in the Sonic Hedgehog Pathway Affect Clinical Outcomes in Non–Muscle-Invasive Bladder Cancer (2010) (53)
- Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients (2017) (52)
- Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer (2013) (52)
- TGF-β Signaling Pathway and Breast Cancer Susceptibility (2011) (51)
- Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. (2015) (51)
- Reproductive risk factors for endometrial cancer among Polish women (2007) (51)
- A cross-sectional study of dental caries, intake of confectionery and foods rich in starch and sugars, and salivary counts of Streptococcus mutans in children in Spain. (1997) (50)
- Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study (2018) (50)
- Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic Studies (2010) (50)
- Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic, March to December 2020 (2021) (50)
- Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2 (2015) (50)
- Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2) (2015) (49)
- Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast (2014) (49)
- Tobacco smoking, NAT2 acetylation genotype and breast cancer risk (2006) (48)
- TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis (2009) (48)
- A role for XRCC2 gene polymorphisms in breast cancer risk and survival (2011) (48)
- Ovarian cancer risk associated with inherited inflammation-related variants. (2012) (48)
- Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study (2007) (47)
- Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry (2016) (47)
- A framework for transcriptome-wide association studies in breast cancer in diverse study populations (2019) (47)
- Genome-wide interaction study of smoking and bladder cancer risk. (2014) (46)
- Genetic predisposition to ductal carcinoma in situ of the breast (2016) (46)
- Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. (2010) (45)
- Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer (2019) (45)
- Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (44)
- DNA mismatch repair gene MSH6 implicated in determining age at natural menopause (2013) (44)
- Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study. (2012) (44)
- Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis (2015) (43)
- Genomic and evolutionary classification of lung cancer in never smokers (2021) (43)
- E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium (2018) (43)
- Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case–control study from Poland (2010) (43)
- Large-Scale Pathway-Based Analysis of Bladder Cancer Genome-Wide Association Data from Five Studies of European Background (2012) (42)
- Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. (2014) (42)
- Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) (42)
- Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study. (2007) (41)
- Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers (2012) (41)
- A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases (2019) (41)
- Immune gene expression profiling reveals heterogeneity in luminal breast tumors (2019) (40)
- Division of Cancer Epidemiology and Genetics (2020) (40)
- Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom (2014) (40)
- A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. (2014) (40)
- Combined Utility of 25 Disease and Risk Factor Polygenic Risk Scores for Stratifying Risk of All-Cause Mortality. (2020) (40)
- Genome-wide association study of endometrial cancer in E2C2 (2013) (40)
- Folate metabolism genes, vegetable intake and renal cancer risk in central Europe (2007) (39)
- Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. (2015) (39)
- 11q13 is a susceptibility locus for hormone receptor positive breast cancer (2012) (38)
- Coffee consumption, genetic susceptibility and bladder cancer risk (2009) (38)
- Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) program (2008) (38)
- Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data. (2012) (38)
- Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom (2012) (38)
- Body mass index and breast cancer survival: a Mendelian randomization analysis (2017) (38)
- Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls (2010) (38)
- Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer (2016) (38)
- Occupational exposure to organic solvents and breast cancer in women (2009) (37)
- Does increased urination frequency protect against bladder cancer? (2008) (37)
- Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status (2014) (37)
- Urinary pH, cigarette smoking and bladder cancer risk. (2011) (36)
- A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6 q 14 and 20 q 11 (2012) (36)
- Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases (2014) (36)
- Urinary bisphenol A-glucuronide and postmenopausal breast cancer in Poland (2014) (36)
- Variability of nasal lavage polymorphonuclear leukocyte counts in unexposed subjects: its potential utility for epidemiology. (1994) (35)
- Investigation of gene‐environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors (2015) (35)
- Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk (2020) (35)
- Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium (2016) (35)
- Mitochondrial DNA Copy Number in Peripheral Blood Cells and Risk of Developing Breast Cancer. (2015) (35)
- An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. (2016) (35)
- Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium (2013) (35)
- Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms. (2015) (34)
- Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women. (2016) (34)
- Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women (2011) (34)
- Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21 (2016) (33)
- Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. (2016) (33)
- Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions (2014) (33)
- iCARE: An R package to build, validate and apply absolute risk models (2020) (33)
- Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer (2011) (33)
- Asbestos-related diseases in construction carpenters. (1995) (33)
- Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (32)
- Molecular Pathology in Epidemiologic Studies: A Primer on Key Considerations (2010) (32)
- Impact of Population Growth and Aging on Estimates of Excess U.S. Deaths During the COVID-19 Pandemic, March to August 2020 (2020) (32)
- Common germline polymorphisms associated with breast cancer-specific survival (2015) (31)
- Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (31)
- Absolute risk models for subtypes of breast cancer. (2007) (30)
- iCARE: R package to build, validate and apply absolute risk models (2016) (30)
- Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk (2019) (29)
- Genetic variation in CYP17 and endometrial cancer risk (2008) (29)
- Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status (2007) (28)
- No Association between FTO or HHEX and Endometrial Cancer Risk (2010) (28)
- Occupation and breast cancer risk in Polish women: a population-based case-control study. (2007) (28)
- Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies (2019) (27)
- A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (27)
- Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. (2020) (27)
- Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs) (2016) (27)
- Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women (2006) (27)
- Prolactin Receptor Expression and Breast Cancer: Relationships with Tumor Characteristics among Pre- and Post-menopausal Women in a Population-Based Case–Control Study from Poland (2014) (27)
- Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes (2022) (27)
- Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study. (2011) (26)
- Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry (2020) (26)
- Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1 (2013) (26)
- Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned. (2007) (26)
- Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer (2013) (26)
- Active and passive cigarette smoking and the risk of endometrial cancer in Poland. (2010) (25)
- Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk (2015) (25)
- Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis (2009) (25)
- Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer (2020) (25)
- Polymorphism in the GALNT1 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women: The Ovarian Cancer Association Consortium (2010) (25)
- Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants (2020) (25)
- Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types (2015) (24)
- Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA (2013) (24)
- Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk. (2006) (23)
- Association of Active and Sedentary Behaviors with Postmenopausal Estrogen Metabolism. (2016) (23)
- Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland (2011) (23)
- Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. (2013) (23)
- High‐throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium (2016) (23)
- Association of ESR 1 gene tagging SNPs with breast cancer risk (2009) (23)
- Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium (2014) (23)
- Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry. (2021) (22)
- Common Genetic Variation in GATA-Binding Protein 3 and Differential Susceptibility to Breast Cancer by Estrogen Receptor α Tumor Status (2007) (22)
- Oncologic therapy shapes the fitness landscape of clonal hematopoiesis (2019) (22)
- FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium (2014) (22)
- Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population‐based case–control study (2019) (22)
- Prediction and clinical utility of a contralateral breast cancer risk model (2019) (22)
- Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome (2013) (22)
- NAT2 slow acetylation and GSTM1 null genotypes increase bladder cancer risk: results from the Spanish Bladder Cancer Study and meta-analyses (2008) (21)
- Inherited Variants in Regulatory T Cell Genes and Outcome of Ovarian Cancer (2013) (21)
- Measurement of Sex Steroid Hormones in Breast Adipocytes: Methods and Implications (2008) (21)
- Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression (2013) (21)
- GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer. (2016) (21)
- The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. (2014) (21)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (20)
- Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) (20)
- Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors (2019) (20)
- Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome (2014) (20)
- Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy (2015) (20)
- LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk (2014) (19)
- Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation (2018) (19)
- Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues (2018) (19)
- Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium (2019) (19)
- MicroRNA Processing and Binding Site Polymorphisms Are Not Replicated in the Ovarian Cancer Association Consortium (2011) (19)
- Gene–environment interactions involving functional variants: Results from the Breast Cancer Association Consortium (2017) (19)
- Micronuclei assessment in the urothelial cells of women using hair dyes and its modulation by genetic polymorphisms. (2008) (19)
- Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries. (2021) (19)
- Intrauterine environment and breast cancer risk in a population‐based case‐control study in Poland (2006) (19)
- Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes. (2019) (19)
- Breast cancer etiology by estrogen and progesterone receptors status: a review (2003) (18)
- The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity (2018) (18)
- Effects of Electron-Beam Irradiation on Whole Genome Amplification (2005) (18)
- No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016) (18)
- Application of Multi-SNP Approaches Bayesian LASSO and AUC-RF to Detect Main Effects of Inflammatory-Gene Variants Associated with Bladder Cancer Risk (2013) (18)
- Genetic Variation in the TP53 Pathway and Bladder Cancer Risk. A Comprehensive Analysis (2014) (18)
- Association of COMT haplotypes and breast cancer risk in caucasian women. (2010) (17)
- Maximizing DNA yield for epidemiologic studies: no more buffy coats? (2013) (16)
- Plasma Carotenoid- and Retinol-Weighted Multi-SNP Scores and Risk of Breast Cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (2013) (16)
- Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status. (2007) (16)
- Quantitation of DNA in buccal cell samples collected in epidemiological studies (2006) (16)
- Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
- LIN 28 B Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer (2011) (16)
- SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival (2015) (15)
- A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC 14 A 1 , a urea transporter gene on chromosome 18 q 12 . 3 (2011) (15)
- Construction and Validation of Tissue Microarrays of Ductal Carcinoma In Situ and Terminal Duct Lobular Units Associated With Invasive Breast Carcinoma (2006) (15)
- Genome-wide CNV analysis replicates the association between GSTM1 deletion and bladder cancer: a support for using continuous measurement from SNP-array data (2012) (15)
- A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (15)
- Skewed X chromosome inactivation and early-onset breast cancer (2005) (15)
- The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients (2015) (15)
- Genetic modifiers of CHEK 2 * 1100 delC-associated breast cancer risk (2017) (15)
- CHEK2, MGMT, SULT1E1 and SULT1A1 Polymorphisms and Endometrial Cancer Risk (2011) (15)
- Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus (2016) (14)
- Clarifying breast cancer risks associated with menopausal hormone therapy. (2006) (14)
- Genetic Variation in the Androgen Receptor Gene and Endometrial Cancer Risk (2009) (14)
- Whole Genome Prediction of Bladder Cancer Risk With the Bayesian LASSO (2014) (14)
- Invited commentary: screening and the elusive etiology of prostate cancer. (2015) (14)
- Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana Breast Health Study (2021) (14)
- Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium (2021) (14)
- Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer. (2015) (14)
- Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. (2014) (14)
- Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17 q 21 . 31 (2013) (14)
- An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer (2016) (14)
- Effects of electron-beam irradiation on buccal-cell DNA. (2003) (13)
- Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer (2017) (13)
- Analysis of epidemiologic studies of genetic effects and gene-environment interactions. (2011) (13)
- HSD17B1 Genetic Variants and Hormone Receptor–Defined Breast Cancer (2008) (13)
- Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome (2013) (12)
- Bladder Cancer, Disinfection Byproducts, and Markers of Genetic Susceptibility in a Case-control Study from Spain (2006) (12)
- A response to “Personalised medicine and population health: breast and ovarian cancer” (2019) (12)
- Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts (2020) (12)
- Association of CYP1B1 Haplotypes and Breast Cancer Risk in Caucasian Women (2009) (12)
- Single Nucleotide Polymorphisms in the TP 53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer (2009) (11)
- Population-based study designs in molecular epidemiology. (2011) (11)
- A mixed-model approach for powerful testing of genetic associations with cancer risk incorporating tumor characteristics (2018) (11)
- Bulky DNA Adduct Formation and Risk of Bladder Cancer (2007) (11)
- Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. (2014) (11)
- Measurement of urine pH for epidemiological studies on bladder cancer (2007) (11)
- Searching for blood DNA methylation markers of breast cancer risk and early detection. (2013) (11)
- Novel Methods for Multi-ancestry Polygenic Prediction and their Evaluations in 5.1 Million Individuals of Diverse Ancestry (2023) (10)
- Prospective Evaluation of a Breast Cancer Risk Model Integrating Classical Risk Factors and Polygenic Risk in 15 Cohorts from Six Countries (2019) (10)
- Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium (2015) (10)
- Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer (2014) (10)
- Toward Risk-Stratified Breast Cancer Screening: Considerations for Changes in Screening Guidelines. (2019) (10)
- Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women (2021) (10)
- Inflammatory-Related Genetic Variants in Non–Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment (2016) (10)
- Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche DTU Orbit (05/11/2017) (2014) (10)
- Asthma status is associated with decreased risk of aggressive urothelial bladder cancer (2018) (10)
- Assessment of breast cancer risk: which tools to use? (2019) (9)
- PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1 (2017) (9)
- Recruiting population controls for case-control studies in sub-Saharan Africa: The Ghana Breast Health Study (2019) (9)
- Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast (2017) (9)
- Evaluation of associations between genetically predicted circulating protein biomarkers and breast cancer risk (2020) (9)
- Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
- Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones. (2007) (8)
- Tracing Lung Cancer Risk Factors Through Mutational Signatures in Never-Smokers. (2020) (8)
- Reply to ‘Mosaic loss of chromosome Y in leukocytes matters’ (2018) (8)
- Design Considerations in Molecular Epidemiology (2009) (8)
- Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia (2015) (8)
- TGF-b Signaling Pathway and Breast Cancer Susceptibility (2011) (7)
- Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers (2015) (7)
- Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting (2019) (7)
- Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study. (2011) (6)
- Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2021) (6)
- Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (6)
- Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients (2015) (6)
- Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk (2011) (6)
- Common breast cancer risk loci predispose to distinct tumor subtypes (2019) (6)
- 7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium (2011) (6)
- Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element (2021) (6)
- Detectible mosaic truncating PPM1D mutations, age and breast cancer risk (2019) (6)
- Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2018) (6)
- Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement (2020) (6)
- Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue (2016) (6)
- CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers (2021) (5)
- Re: More data regarding the effects of passive smoking on breast cancer risk among younger women (2007) (5)
- Distinct reproductive risk profiles for intrinsic-like breast cancer subtypes: pooled analysis of population-based studies. (2022) (5)
- The case for increasing diversity in tissue-based functional genomics datasets to understand human disease susceptibility (2022) (5)
- Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk (2007) (5)
- Gene-Level Germline Contributions to Clinical Risk of Recurrence Scores in Black and White Patients with Breast Cancer (2021) (4)
- Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups (2016) (4)
- The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study (2022) (4)
- Targeted Deep Sequencing of Bladder Tumors Reveals Novel Associations between Cancer Gene Mutations and Mutational Signatures with Major Risk Factors (2019) (4)
- Genomic DNA Hypomethylation is a Biomarker for Bladder Cancer Susceptibility in the Spanish Bladder Cancer Case-Control Study (2008) (4)
- Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (4)
- Publisher Correction: Shared heritability and functional enrichment across six solid cancers (2019) (4)
- Oncologic Therapy for Solid Tumors Alters the Risk of Clonal Hematopoiesis (2018) (4)
- Incorporating progesterone receptor expression into the PREDICT breast prognostic model. (2022) (4)
- Correction: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer (2016) (4)
- Fine mapping of 14q24.1 breast cancer susceptibility locus (2012) (4)
- Browser-based Data Annotation, Active Learning, and Real-Time Distribution of Artificial Intelligence Models: From Tumor Tissue Microarrays to COVID-19 Radiology (2021) (3)
- Tumor-Associated Stromal Cellular Density as a Predictor of Recurrence and Mortality in Breast Cancer: Results from Ethnically Diverse Study Populations (2021) (3)
- Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast (2020) (3)
- RE: Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic. (2015) (3)
- Smoking and Bladder Cancer in Spain: Effects of tobacco Type, Timing, Ets and Gender (2006) (3)
- Comment on: Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. Authors' reply (2004) (3)
- Circulating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in Africa (2020) (3)
- Cancer Informatics for Cancer Centers (CI4CC): Building a Community Focused on Sharing Ideas and Best Practices to Improve Cancer Care and Patient Outcomes. (2020) (3)
- Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer (2013) (3)
- Comparison of somatic mutation landscapes in Chinese versus European breast cancer patients (2021) (3)
- Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment (2021) (3)
- Mendelian randomisation study of smoking exposure in relation to breast cancer risk (2021) (3)
- Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020) (3)
- Peripheral blood immunologic phenotype of population‐based breast cancer cases and matched controls (2012) (2)
- Abstract 3670: Systematic literature review of risk factor associations with breast cancer subtypes in women of African, Asian, Hispanic, and European descents (2022) (2)
- A Genome-Wide Gene-Based Gene–Environment Interaction Study of Breast Cancer in More than 90,000 Women (2022) (2)
- Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers (2012) (2)
- PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (2022) (2)
- Plus : development and validation of a prognostic model for early breast cancer that includes HER 2 (2012) (2)
- rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk (2016) (2)
- Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) (2)
- Promise of Risk Stratification for Multicancer Screening with Liquid Biopsy Tests (2021) (2)
- Abstract 2201: Pathway analysis of breast cancer genome wide association study highlights three pathways and one canonical signaling cascade (2010) (2)
- Abstract 3286: Breast cancer risk factors and survival by tumor subtypes: A pooled analysis from the breast cancer association consortium studies (2019) (2)
- Abstract 2567: Genetic risk stratification for breast cancer based on a polygenic risk score and family history. (2013) (2)
- E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium (2018) (2)
- Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium: Automated scoring of breast tumor TMAs (2014) (2)
- Breast Cancer Risk FromModifiable and Nonmodifiable Risk Factors AmongWhiteWomen in the United States (2016) (2)
- Impact of breast cancer risk factors on clinically relevant prognostic biomarkers for primary breast cancer (2021) (2)
- Annexin A 1 expression in a pooled breast cancer series (2)
- Two truncating variants in FANCC and breast cancer risk (2019) (2)
- Heterocyclic aromatic amines: genetic susceptibility (2000) (2)
- Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study (2022) (2)
- Abstract 870: Analysis of breast cancer risk factors by expression of tumor markers: results of 34 studies in the Breast Cancer Association Consortium (BCAC) (2010) (1)
- Gene-level germline contributions to clinical risk of recurrence scores in Black and White breast cancer patients (2021) (1)
- Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry (2016) (1)
- Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study (2022) (1)
- A novel functional variant in 8q24 is associated with regulation of prostate stem cell antigen (PSCA) gene expression and bladder cancer risk (2011) (1)
- Abstract SY26-02: Sherlock-Lung: Tracing lung cancer mutational processes in never smokers (2019) (1)
- Disinfection By-Products in Drinking Water and Bladder Cancer: Evaluation of Risk Modification by Common Genetic Polymorphisms in Two Case–Control Studies (2022) (1)
- Genetic variation in nucleotide excision repair (NER) and bladder cancer risk in the Spanish Bladder Cancer Study (2005) (1)
- Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk (2007) (1)
- Large-scale evaluation of candidate genes for urinary bladder cancer susceptibility using Illumina® in the Spanish Bladder Cancer Study (2006) (1)
- Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast (2020) (1)
- Prostate Cancer Susceptibility Polymorphism rs2660753 Is Not Associated with Invasive Ovarian Cancer (2011) (1)
- Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium (2013) (1)
- Abstract P3-08-02: Common variants at 10p14 and 1p11.2 display heterogeneity in breast cancer associations by E-cadherin tumor tissue expression in two independent datasets (2012) (1)
- Identifying 31 novel breast cancer susceptibility loci using data from genome-wide association studies conducted in Asian and European women (2019) (1)
- Cross-ancestry GWAS meta-analysis identifies six new loci for breast cancer in women of African and European ancestry (2021) (1)
- Discovery of structural deletions in breast cancer predisposition genes using whole genome sequencing data from > 2000 women of African-ancestry (2021) (1)
- Abstract 3230: Genome-wide blood DNA methylation and breast cancer risk: A meta-analysis of four prospective studies (2018) (1)
- Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (1)
- A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (1)
- Abstract 1225: Rare variants in DNA damage repair genes are associated with male breast cancer predisposition (2018) (1)
- Towards implementation of comprehensive breast cancer risk prediction tools in health care for personalised prevention. (2022) (1)
- Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium (2015) (1)
- Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy (2015) (1)
- Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status (2014) (1)
- Identification of nine new susceptibility loci for endometrial cancer (2018) (1)
- Mosaic loss of chromosome Y is associated with common variation near TCL 1 A 1 2 (2016) (1)
- Modifications to a Standard Buccal Collection Protocol: Effects on Human DNA Yield (2007) (1)
- Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants (2020) (1)
- Abstract PR02: Validation of breast cancer risk prediction model using Nurses Health and Nurse Health II Studies (2017) (1)
- A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer (2021) (1)
- GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas (2023) (1)
- Abstract 2519: Is accelerometer-measured physical activity associated with urinary estrogens and estrogen metabolites among postmenopausal women?. (2013) (1)
- Transcriptome-wide association study of risk of recurrence in Black and White breast cancer patients (2021) (1)
- Abstract LB-178: Performance of breast cancer polygenic risk score (PRS) in a Ghanaian population (2019) (1)
- Rare germline copy number variants (CNVs) and breast cancer risk (2022) (1)
- Genetic predisposition to ductal carcinoma in situ of the breast (2016) (1)
- PLCOjs, a FAIR GWAS web SDK for the NCI Prostate, Lung, Colorectal and Ovarian Cancer Genetic Atlas project (2022) (1)
- Prediction and clinical utility of a contralateral breast cancer risk model (2019) (1)
- Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers (2020) (1)
- IDENTIFICATION AND REPLICATION OF THE INTERPLAY OF FOUR GENETIC HIGH‐RISK VARIANTS FOR URINARY BLADDER CANCER: MP54‐11 (2018) (1)
- Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis association study reveals decreased average methylation levels years before breast cancer (2018) (1)
- Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies (2019) (1)
- Syddansk Universitet Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12 p 11 locus (2016) (1)
- Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana (2022) (1)
- Abstract 1029: The association of body mass index with risk of endometrial cancer subtypes: Pooled analysis in E2C2 (2012) (1)
- Moving towards FAIR practices in epidemiological research. (2022) (1)
- The ATM missense mutation Ser49Cys and risk of breast cancer (2008) (1)
- Abstract 2779: Relationship of mammographic density with breast cancer subtypes (2010) (1)
- Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis (2015) (1)
- Large-scale evaluation of candidate genes for cancer identifies common genetic variants in vascular endothelial growth factor associated with bladder cancer risk (2005) (1)
- Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk (2019) (1)
- Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases (2022) (1)
- Genome-wide association study of germline variants and breast cancer-speci fi c mortality (2019) (1)
- Abstract 2278: Risk factors by molecular subtypes of breast cancer: a pooled analysis of nine cohorts (2017) (1)
- Polygenic Risk Scores for Prediction of Breast Cancer Risk in Women of African Ancestry: a Cross-Ancestry Approach (2021) (0)
- Discovery of structural deletions in breast cancer susceptibility genes using whole genome sequencing data from >2,000 African ancestry women (2020) (0)
- Abstract 876: TP53 pathway function, estrogen receptor status, and breast cancer risk factors in the Carolina Breast Cancer Study (2021) (0)
- Annexin A1 expression in breast cancer: tumor subtypes and prognosis (2015) (0)
- CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers (2021) (0)
- TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study (2021) (0)
- An Improved Polygenic Risk Score for Risk Prediction in Breast Cancer (2017) (0)
- A cross-sectional study of dental caries , intake of confectioneryand foods rich in starchand sugars , and salivarycountsof Streptococcusmutansin childrenin Spain (0)
- Abstract 962: Validation of breast cancer risk model incorporating classical risk factors and polygenic risk scores in 14 prospective cohort studies in 6 countries (2019) (0)
- Abstract 861: Relationships of prolactin serum levels to breast cancer risk and tumor characteristics in a population-based case-control study from Poland (2010) (0)
- Genetic Risk Factors for Breast Cancer Subtypes (2011) (0)
- Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (0)
- Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry (2023) (0)
- FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. (2023) (0)
- Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2022) (0)
- Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival (2023) (0)
- Abstract SY26-02:Sherlock-Lung: Tracing lung cancer mutational processes in never smokers (2019) (0)
- Abstract 622: Reproductive factors and breast cancer risk to women in Ghana, West Africa (2019) (0)
- Abstract A111: Genetic variations in five estrogen metabolizing genes and endometrial cancer risk (2008) (0)
- Abstract P1-04-01: Epigenome-wide association study for breast cancer risk using whole genome and target captured bisulphite sequencing: A pooled case-control study nested in the breakthrough generations study (2017) (0)
- Interplay of four genetic high risk variants for urinary bladder cancer (2018) (0)
- Abstract 81: Studying Ghanian Cancer Genomes Using Cell-free DNA (2021) (0)
- Abstract 5703: Oncologic therapy shapes the fitness landscape of clonal hematopoiesis (2020) (0)
- Reply: Study design and statistics in epidemiology of breast cancer (2006) (0)
- 53 Assessing interaction between established breast cancer genetic susceptibility loci and selected non-genetic risk factors using data from the Breast Cancer Association Consortium (2010) (0)
- Immune gene expression profiling reveals heterogeneity in luminal breast tumors (2019) (0)
- Abstract 865: Genomic and evolutionary classification of lung cancer in never smokers from the Sherlock-Lungstudy (2021) (0)
- Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (2022) (0)
- Genome-wide association study of germline variants and breast cancer-speci fi c mortality (2019) (0)
- Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting (2019) (0)
- Abstract P3-12-05: Genetic Variation in Prolactin and Prolactin Receptor, and Relationships with Serum Prolactin Levels and Breast Cancer Risk (2010) (0)
- Urinary bisphenol A-glucuronide and postmenopausal breast cancer in Poland (2014) (0)
- Modelling the overdiagnosis of breast cancer due to mammography screening in womenaged 40 to 49 in the United Kingdom (2012) (0)
- Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) (0)
- Abstract 2786: Methylation profiling of endometrial cancers from a population-based case control study (2010) (0)
- the Breast Cancer Association Consortium Five Polymorphisms and Breast Cancer Risk : Results from Updated (2009) (0)
- Reproductive Factors and Risk of Breast Cancer by Tumour Subtypes Among Ghanaian Women: A Population-Based Case-Control Study (2019) (0)
- Association of rs12662670 with breast cancer in Asian ER (2012) (0)
- Abstract LB-304: Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis (2019) (0)
- Abstract 5012: DNA methylation profiles of endometrial cancer and benign endometrium suggest differences by mismatch repair status and possible early detection markers (2012) (0)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (0)
- Cross-cancer genome-wide association analysis of lung, ovary, breast, prostate and colon cancer identifies a novel cancer locus at 1q22 (2015) (0)
- Occupational Physical Activity and Risk of Breast Cancer in Polish Women (2006) (0)
- Abstract 3651: Parity-related molecular signatures and breast cancer heterogeneity. (2013) (0)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
- Study of genes and environmental factors in complex diseases (2002) (0)
- Associations of breast cancer etiologic factors with stromal microenvironment of primary invasive breast cancers in the Ghana Breast Health Study (2023) (0)
- Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: a pooled analysis of four prospective studies (2022) (0)
- Abstract 2256: Validation of an integrated breast cancer risk model with mammographic density in three prospective cohort studies (2022) (0)
- Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients (2017) (0)
- sense Variants in ATM in 26 , 101 Breast Cancer B & P es and 29 , 842 Controls (2010) (0)
- Abstract 4722: Evaluation of common genetic variation in 1,300 cancer-related candidate genes and endometrial cancer risk (2010) (0)
- Abstract 620: Evaluating multiple tumor markers in a novel analysis of reproductive factors and breast cancer risk (2019) (0)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
- Abstract 2167: Infertility and risk of incident endometrial carcinoma: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (2014) (0)
- Abstract LB-454: Serum metabolic profiles and endometrial cancer (2011) (0)
- Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: a pooled analysis of four prospective studies (2022) (0)
- Erratum: Intrauterine environment and breast cancer risk in a population-based case-control study in Poland (International Journal of Cancer (2006) 119, (2136-2141)) (2007) (0)
- Cyclin D polymorphisms and breast cancer risk in a US population-based study (2007) (0)
- Interpretable, non-mechanistic forecasting using empirical dynamic modeling and interactive visualization (2022) (0)
- Abstract LB-413: A multi-stage association study in breast cancer identifies a protective allele at NCOA7 (2010) (0)
- Shared heritability and functional enrichment across six solid cancers (2019) (0)
- Genetic variation in the immunosuppression pathway genes and breast cancer: a pooled analysis of 42,510 cases and 40,577 controls from the Breast (2015) (0)
- Abstract 28: Integrating genomic and transcriptomic data to identify genetic loci associated with breast cancer risk in women of African ancestry (2020) (0)
- Abstract 4680: Exploring the relationships between genetic variants within the UGT1A locus, cellular detoxification and risk of bladder cancer (2011) (0)
- Abstract LB-051: Integrative, targeted deep sequencing of bladder tumors reveals novel associations between cancer gene mutations and mutational signatures with major risk factors (2019) (0)
- Abstract 2850: Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2: results and replication in two case-control studies (2010) (0)
- Correction to: Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana (2022) (0)
- Abstract 4636: Breast cancer age-specific incidence rates among Ghanaian women by breast cancer risk factors: A study using census and population-based case-control study data (2020) (0)
- Abstract PO-093: Circulating tumor DNA (ctDNA) from peripheral blood is detectable among Ghanaian breast cancer patients (2020) (0)
- Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium (2016) (0)
- Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women (2021) (0)
- The impact of coding germline variants on contralateral breast cancer risk and survival (2023) (0)
- Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting (2022) (0)
- A gap analysis for breast cancer research: identifying translational priorities (2013) (0)
- Detectible mosaic truncating PPM1D mutations, age and breast cancer risk (2019) (0)
- 1 LIN 28 B polymorphisms influence susceptibility to epithelial ovarian cancer (2011) (0)
- Potential utility of risk stratification for multicancer screening with liquid biopsy tests (2023) (0)
- Associations of life course obesity with endometrial cancer in the Epidemiology of Endometrial Cancer Consortium (E2C2). (2023) (0)
- Fine-mapping identifies two additional susceptibility 9q31.2. (2015) (0)
- Fine mapping of 14q24.1 breast cancer susceptibility locus (2011) (0)
- Abstract 2767: Investigation of the relationship between crown-like structures and adipose tissue hormone levels among postmenopausal women with breast cancer (2015) (0)
- Heterogeneity of the Arsenic-Bladder Cancer Relationship by Tumor p16/Rb Immunophenotype (2018) (0)
- Prevention and Epidemiology Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk (2012) (0)
- Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (0)
- Abstract 5570: Heterogeneity of luminal breast cancer characterized by immunohistochemical expression of basal markers (2015) (0)
- N-ACETYL TRANSFERASE AND GLUTATHIONE S-TRANSFERASE GENETIC VARIANTS AND OUTCOME OF BLADDER CANCER (2006) (0)
- Prevention and Epidemiology LIN 28 B Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer (2011) (0)
- 1277 URINARY PH, CIGARETTE SMOKING AND BLADDER CANCER RISK (2012) (0)
- Abstract ED3-3: Etiological clues from breast cancer GWAS (2010) (0)
- Breast cancer risk in women from Ghana carrying rare germline pathogenic mutations. (2022) (0)
- Abstract 2927: MicroRNA binding site polymorphisms influence ovarian cancer risk in the collaborative oncological gene-environment study (2012) (0)
- Abstract 5290: Racial variation in terminal duct lobular unit (TDLU) involution in Chinese and Polish breast cancer patients (2017) (0)
- Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study (2022) (0)
- P270: Characterizing clinical actionability in the context of polygenic risk assessment* (2023) (0)
- A novel functional variant in 8q24 is associated with regulation of prostate stem cell antigen (PSCA) gene expression and bladder cancer risk (2011) (0)
- CHEK 2 , MGMT , SULT 1 E 1 and SULT 1 A 1 Polymorphisms and Endometrial Cancer Risk (2011) (0)
- Abstract 1658: Post-GWAS genetic and functional studies for bladder cancer: An uncommon protective synonymous coding variant within the UGT1A6 gene explains the GWAS signal and affects cellular detoxification (2012) (0)
- An unusual suspect: an uncommon human-specific synonymous coding variant within the UGT1A6 gene explains a GWAS signal and protects against bladder cancer (2011) (0)
- Risk prediction models for endometrial cancer: development and validation in an international consortium. (2023) (0)
- Abstract 2211: Patient level polygenic risk scores and continuous estrogen receptor expression in breast cancer (2018) (0)
- BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors (2019) (0)
- Abstract 874: Autoantibody biomarker discovery in basal-like breast cancer using nucleic acid programmable protein array (2014) (0)
- Abstract 2971: Digital image analysis based IHC4+C assay and prognosis in hormone receptor-positive breast cancer (2018) (0)
- Results in Brief Association between FTO or HHEX and Endometrial B & P cer Risk (2010) (0)
- A framework for transcriptome-wide association studies in breast cancer in diverse study populations (2020) (0)
- Reply to ‘Mosaic loss of chromosome Y in leukocytes matters’ (2018) (0)
- Abstract 4613: Cross-ancestry genome-wide association study identifies six new loci for breast cancer in women of African and european ancestry (2020) (0)
- Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (0)
- A response to “Personalised medicine and population health: breast and ovarian cancer” (2019) (0)
- A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (0)
- Common germline polymorphisms associated with breast cancer-specific survival (2015) (0)
- Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis (2021) (0)
- Function and Aggressive Disease The 19 q 12 Bladder Cancer GWAS Signal : Association with Cyclin E Updated (2014) (0)
- Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA (2013) (0)
- Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors (2019) (0)
- Abstract A81: Relationships between expression of TGF-β factors and breast tumor characteristics in a population-based study from Poland (2009) (0)
- Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations: A Resource for Genetic Counseling of West African Women (2021) (0)
- Ovarian Cancer Control Genes and Susceptibility to Invasive Epithelial Tagging Single Nucleotide Polymorphisms in Cell Cycle (2007) (0)
- Selenoproteins and bladder cancer risk: A case-control study (2010) (0)
- a novel candidate breast cancer susceptibility locus on (2017) (0)
- Abstract 2783: A novel functional variant is associated with regulation of the prostate stem cell antigen (PSCA) gene and bladder cancer risk in males (2011) (0)
- Contributions — B: Carcinogenic Factors: Exogenous (2006) (0)
- Abstract 3451: Breast cancer risk factor associations by loss of E-cadherin tumor tissue expression: A pooled analysis of 5,896 cases in 12 studies from the Breast Cancer Association Consortium (BCAC) (2016) (0)
- Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry (2021) (0)
- 1042 Association between PDL1 variants and muscle invasive bladder cancer prognosis (2016) (0)
- ImageBox3: No-Server Tile Serving to Traverse Whole Slide Images on the Web (2022) (0)
- Abstract 2320: Evaluating a polygenic risk score for breast cancer in women of African ancestry (2020) (0)
- Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (0)
- Abstract 3762: Automated analysis of breast cancer tissue microarrays to investigate etiologic heterogeneity in the Breast Cancer Association Consortium (2010) (0)
- Low predictive ability of low penetrance genetic variants for bladder cancer risk among non-smokers (2012) (0)
- Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases (2022) (0)
- The sequence kernel association test for multicategorical outcomes. (2023) (0)
- Association of germline genetic variants with breast cancer survival in patient subgroups defined by standard clinic-pathological variables (2020) (0)
- Practice of Epidemiology Maximizing DNAYield for Epidemiologic Studies : No More Buffy Coats ? (2013) (0)
- Estrogen receptor negative breast cancer incidence rates are similar in Ghanaian and Non-Hispanic Black women in the USA (2022) (0)
- Abstract LB-337: Synergistic effects of twelve common genetic polymorphisms and smoking habits on absolute risk of bladder cancer (2012) (0)
- Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
- Abstract 2603: Subtype-specific ovarian cancer risk associated with SNPs inIL1A: (2012) (0)
- Genome-wide CNV analysis replicates the association between GSTM1 deletion and bladder cancer: a support for using continuous measurement from SNP-array data (2012) (0)
- Abstract 5483: CYP19A1 genetic variation is a potential predictor of outcome in ER-positive postmenopausal early breast cancer patients treated with tamoxifen (2015) (0)
- Abstract 154: Lifetime ovulatory cycles and risk of ovarian and endometrial cancers. (2013) (0)
- ATM intragenic methylation as a breast cancer risk marker-1-Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk (2012) (0)
- 1275 THE EFFECTS OF SMOKING STATUS, URINATION FREQUENCY, WATER INTAKE AND COFFE CONSUPTION STATUS ON BLADDER CANCER RISK (2012) (0)
- 42 THE EFFECTS OF URINARION FREQUENCY, WATER INTAKE AND SMOKING STATUS ON BLADDER CANCER RISK (2010) (0)
- Abstract LB-336: Association of variant rs2046210 at 6q25.1 (ESR1) with breast cancer risk suggests heterogeneity by E-cadherin tumor tissue expression (2012) (0)
- Abstract 4729: A genome-wide association study of ovarian cancer prognosis identifies a novel locus for aggressive serous cancer on 19p13 (2010) (0)
- Rare copy number variants (CNVs) and breast cancer risk (2021) (0)
- Genome-wide association study of endometrial cancer in E2C2 (2013) (0)
- Abstract 4638: Associations of fecal microbial profiles with non-malignant breast disease and breast cancer in the Ghana Breast Health Study (2020) (0)
- Genetic Variation of Tumor Necrosis Factor-alpha (TNF) and Risk of Breast Cancer (2006) (0)
- Practice of Epidemiology Likelihood Ratio Test for Detecting Gene ( G )-Environment ( E ) Interactions Under an Additive Risk Model Exploiting G - E Independence for Case-Control Data (2012) (0)
- An unusual suspect: an uncommon human-specific synonymous coding variant within the UGT1A6 gene explains a GWAS signal and protects against bladder cancer (2011) (0)
- Abstract 826: Large-scale genome-wide association study identifies multiple novel germline susceptibility variants associated with bladder cancer risk (2021) (0)
- DNA methylation age in paired tumor and adjacent normal breast tissue in Chinese women with breast cancer (2023) (0)
- Variation in NFk B Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer (2014) (0)
- Combined Utility of 25 Disease and Risk Factor Polygenic Risk Scores for Stratifying Risk of All-Cause Mortality (2020) (0)
- Null Results in Brief Association of CYP 1 B 1 Haplotypes and Breast Cancer Risk in Caucasian Women (2009) (0)
- Abstract LB-330: Genetic variants in the 9p21 region in relation to the risk of multiple tumors (2012) (0)
This paper list is powered by the following services:
Other Resources About Montserrat García-Closas
What Schools Are Affiliated With Montserrat García-Closas?
Montserrat García-Closas is affiliated with the following schools:
